Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1989;14:87-97

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seymour, A. A.
Right arrow Articles by Swerdel, J. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seymour, A. A.
Right arrow Articles by Swerdel, J. N.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*POTASSIUM

Hypertension, Vol 14, 87-97, Copyright © 1989 by American Heart Association


ARTICLES

Potentiation of renal effects of atrial natriuretic factor-(99-126) by SQ 29,072

AA Seymour, SA Fennell and JN Swerdel
Department of Pharmacology, Squibb Institute for Medical Research, Princeton, New Jersey 08540.

Depressor and renal activities of atrial natriuretic factor-(99-126) were determined in conscious, unrestrained spontaneously hypertensive rats treated with a neutral endopeptidase inhibitor, SQ 29,072 (7-[[2- (mercaptomethyl)-1-oxo-3-phenylpropyl]amino]heptanoic acid). SQ 29,072 (100 mumol/kg i.v.) prolonged the transient depressor effects of the peptide for as long as 2 hours. During the first hour after 3, 10, and 30 nmol/kg atrial natriuretic factor, urinary excretion of cyclic 3'5' guanosine monophosphate was significantly increased by 9.2 +/- 3.4, 13.0 +/- 2.2, and 12.7 +/- 4.2 nmol/kg/hr, respectively, in vehicle- treated rats and by 26.9 +/- 7.9, 52.1 +/- 11.1, and 46.4 +/- 12.2 nmol/kg/hr, respectively, in rats given 100 mumol/kg SQ 29,072. During the first hour after 3 and 10 nmol/kg atrial natriuretic factor-(99- 126), the sodium loss was 161 +/- 56 and 139 +/- 42 mueq/kg/hr in vehicle-treated rats and was significantly greater (694 +/- 316 and 1,038 +/- 135 mueq/kg/hr) in rats given 100 mumol/kg SQ 29,072. After administration of 3, 10, and 30 mumol/kg SQ 29,072, the area over the curves of the depressor responses to 3 nmol/kg of the peptide increased from 297 +/- 70 to 306 +/- 108, 440 +/- 143, and 669 +/- 186 mm Hg.min, respectively, while the concurrent natriuretic responses rose from 161 +/- 56 to 250 +/- 88, 332 +/- 142, 464 +/- 164, and 694 +/- 316 mueq/kg/hr. In summary, the neutral endopeptidase inhibitor SQ 29,072 increased the magnitudes and especially the durations of the depressor, natriuretic, and cyclic guanosine monophosphate responses to exogenous atrial natriuretic factor-(99-126) in conscious spontaneously hypertensive rats, presumably by inhibition of degradation of atrial natriuretic factor in vivo. In conclusion, neutral endopeptidase inhibition offers an important new technique for enhancement and prolongation of the biological lifetime of atrial natriuretic factor.


This article has been cited by other articles:


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
K. H Chee, K. Amudha, N. A Hussain, H. K Haizal, A.-M. J Choy, and C. C Lang
Combination of drugs acting on the natriuretic system and the renin-angiotensin system in heart failure
Journal of Renin-Angiotensin-Aldosterone System, September 1, 2003; 4(3): 140 - 148.
[Abstract] [PDF]


Home page
HypertensionHome page
V. M. Campese, K. C. Lasseter, C. M. Ferrario, W. B. Smith, M. C. Ruddy, C. E. Grim, R. D. Smith, R. Vargas, M. F. Habashy, O. Vesterqvist, et al.
Omapatrilat Versus Lisinopril: Efficacy and Neurohormonal Profile in Salt-Sensitive Hypertensive Patients
Hypertension, December 1, 2001; 38(6): 1342 - 1348.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. E. Chatelain, R. D. Ghai, A. J. Trapani, L. M. Odorico, B. N. Dardik, S. De Lombaert, R. W. Lappe, and C. A. Fink
Antihypertensive and Natriuretic Effects of CGS 30440, a Dual Inhibitor of Angiotensin-Converting Enzyme and Neutral Endopeptidase 24.11
J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 974 - 982.
[Abstract] [Full Text]


Home page
HypertensionHome page
A. A. Seymour, M. M. Asaad, J. H. Sheldon, P. L. Smith, and W. L. Rogers
Atrial Natriuretic Peptide in Chronically Hypertensive Dogs
Hypertension, October 1, 1995; 26(4): 634 - 641.
[Abstract] [Full Text]